Drug Study - Phenobarbital Sodium

Posted by: Admin

To receive automatic updates of Nursing News, Nursing Care Plans, Case Studies and the much awaited November 2008 Nursing Board Exam Result: click Subscribe to NursingCrib.com by Email or via RSS. If you have other topics to discuss, make a post on our Nursing Crib Forum. Thanks for visiting and enjoy your stay!

Luminal Sodium

Action:

Long-acting barbiturate. Sedative and hypnotic effects of barbiturates appear to be due primarily to interference with impulse transmission of cerebral cortex by inhibition of reticular activating system. CNS depression may range from mild sedation to coma, depending on dosage, route of administration, degree of nervous system excitability, and drug tolerance. Initially, barbiturates suppress REM sleep, but with chronic therapy REM sleep returns to normal.

Classification:

CENTRAL NERVOUS SYSTEM AGENT; ANTICONVULSANT; SEDATIVE-HYPNOTIC; BARBITURATE

Indication:

Long-term management of tonic-clonic (grand mal) seizures and partial seizures; status epilepticus, eclampsia, febrile convulsions in young children. Also used as a sedative in anxiety or tension states; in pediatrics as preoperative and postoperative sedation and to treat pylorospasm in infants.

DOWNLOAD

by: ishi21marie

_____________________________________________________________________________________________

• Drug Study - Diazepam Action: Psychotherapeutic agent related to chlordiazepoxide; reportedly superior in antianxiety and anticonvulsant activity, with somewhat shorter duration of action. Like chlordiazepoxide, it appears to act at both limbic and subcortical levels of CNS. Classifications: CENTRAL NERVOUS SYSTEM AGENT; BENZODIAZEPINE ANTICONVULSANT; ANXIOLYTIC Indication: Drug of choice for status epilepticus. Management of anxiety disorders, for short-term relief of anxiety symptoms, to
• Drug Study - Prozinc Multivitamins Indication: Promotes normal biochemical reactions, strengthens the immune system, supports normal growth and development and helps prevent growth retardation in children and young adult. Classification: Multivitamins and minerals Dosage: Young adult and children 2.5 – 5 ml once daily. Young children and infants 0.5 – 1 ml once daily. DOWNLOAD
• Drug Study - Dopamine Hydrochloride by: ishi21, RN Dopastat, Intropin, Revimine Action: Naturally occurring neurotransmitter and immediate precursor of norepinephrine. Major cardiovascular effects produced by direct action on alpha- and beta-adrenergic receptors and on specific dopaminergic receptors in mesenteric and renal vascular beds. Classifications: AUTONOMIC NERVOUS SYSTEM AGENT; ALPHA- AND BETA-ADRENERGIC AGONIST (SYMPATHOMIMETIC) Indication: To correct hemodynamic imbalance in shock syndrome due to MI (cardiogenic shock),
• Drug Study - Clonidine Hydrochloride Catapres, Catapres-TTS, Dixaril , Duraclon Action: Centrally acting antiadrenergic derivative. Stimulates alpha2-adrenergic receptors in CNS to inhibit sympathetic vasomotor centers. Central actions reduce plasma concentrations of norepinephrine. It decreases systolic and diastolic BP and heart rate. Orthostatic effects tend to be mild and occur infrequently. Also inhibits renin release from kidneys.. Classifications: cardiovascular agent; central-acting antihypertensive; analgesic Indication: Step 2 drug
• Drug Study - Furosemide Fumide , Furomide , Lasix, Luramide Action: Rapid-acting potent sulfonamide “loop” diuretic and antihypertensive with pharmacologic effects and uses almost identical to those of ethacrynic acid. Exact mode of action not clearly defined; decreases renal vascular resistance and may increase renal blood flow. Classification: ELECTROLYTIC AND WATER BALANCE AGENT; LOOP DIURETIC Indication: Treatment of edema associated with CHF, cirrhosis of liver,